Evidence map›Paper›PMID 21666830›Full record

ArticleACS medicinal chemistry letters2011

Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors

Anna W Sromek, Yu-Gui Si, Tangzhi Zhang, Susan R George, Philip Seeman, John L Neumeyer

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Characterization of [ACS omega · 2026
    Article
  2. Natural Product-Inspired Dopamine Receptor Ligands.Journal of medicinal chemistry · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. The High Affinity Dopamine DACS chemical neuroscience · 2021
    Article
  7. Review
  8. New Dopamine D2 Receptor Agonist, [ACS chemical neuroscience · 2018
    Article
  9. Article
  10. (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna W SromekAlcohol & Drug Abuse Research Center, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478-9106 USA.
Yu-Gui Si
Tangzhi Zhang
Susan R George
Philip Seeman
John L Neumeyer

Funding

DRUG ABUSE RESEARCH TRAINING PROGRAMT32DA007252 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI MELLO, NANCY K. · 1991 to 2011
$3.0M
RECEPTORS MEDIATING DRUG DEPENDENCER01DA007223 · NIDA · UNIVERSITY OF TORONTO · PI GEORGE, SUSAN R · 1991 to 2013
$2.5M
NIDA NIH HHS R01 DA007223NIDA NIH HHS T32 DA007252
6 · The paper itself

Abstract

The 2-fluoroalkoxy substituted catechol-aporphines 6, 8a-f and 11-monohydroxyaporphines 11a-e were synthesized and found to have high in vitro affinity and selectivity for the dopamine D(2) receptors. The catechol aporphines, 8b and 8d, and the monohydroxy aporphines, 11a-d, were identified as candidates for development as potential PET ligands.

Identifiers

PMID21666830
PMCPMC3110009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.